First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study.
about
Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial.Polymer-drug conjugates: recent development in clinical oncologyRole of taxane and anthracycline combination regimens in the management of advanced breast cancer: a meta-analysis of randomized trials.Multifunctional synthetic poly(L-glutamic acid)-based cancer therapeutic and imaging agents.Inhibition of ERα/ERK/P62 cascades induces "autophagic switch" in the estrogen receptor-positive breast cancer cells exposed to gemcitabine
P2860
First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
First-line therapy with gemcit ...... reast cancer: a phase II study
@nl
First-line therapy with gemcit ...... east cancer: a phase II study.
@ast
First-line therapy with gemcit ...... east cancer: a phase II study.
@en
type
label
First-line therapy with gemcit ...... reast cancer: a phase II study
@nl
First-line therapy with gemcit ...... east cancer: a phase II study.
@ast
First-line therapy with gemcit ...... east cancer: a phase II study.
@en
prefLabel
First-line therapy with gemcit ...... reast cancer: a phase II study
@nl
First-line therapy with gemcit ...... east cancer: a phase II study.
@ast
First-line therapy with gemcit ...... east cancer: a phase II study.
@en
P2093
P2860
P3181
P356
P1433
P1476
First-line therapy with gemcit ...... east cancer: a phase II study.
@en
P2093
Djelila Allouache
Fawzia Mefti
Jean-Yves Genot
Laurence Bozec
Michele Tubiana-Hulin
Nicole Tubiana-Mathieu
Sulochana R Gawande
P2860
P2888
P3181
P356
10.1186/1471-2407-5-151
P407
P577
2005-11-29T00:00:00Z
P5875
P6179
1046965588